ClinicalTrials.gg
Not yet recruitingNCT07515001LUS-POSTOPUpdated Apr 7, 2026

Lung Ultrasound Score and Postoperative Pulmonary Complications in Major Non-Thoracic Surgery

An observational study in Postoperative Pulmonary Complications (PPCs) and Hypoxemia, sponsored by Dicle University. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-04-07.

Sponsored by Dicle University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
97
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This prospective observational cohort study aims to evaluate the predictive value of perioperative lung ultrasound (LUS) score in determining early postoperative oxygen requirement and pulmonary complications in patients undergoing major non-thoracic surgery. Postoperative pulmonary complications remain a significant cause of morbidity and mortality in surgical patients. Lung ultrasound is a non-invasive, bedside imaging modality that allows real-time assessment of lung aeration and pathology. This study will investigate the association between perioperative LUS score and early postoperative respiratory outcomes, including oxygen requirement and pulmonary complications.

Read the detailed description

Postoperative pulmonary complications are among the most common causes of postoperative morbidity and prolonged hospital stay following major surgery. Early identification of patients at risk is crucial for timely intervention and improved outcomes. Lung ultrasound (LUS) has emerged as a reliable, non-invasive, and bedside tool for evaluating lung aeration and detecting pulmonary abnormalities such as atelectasis, interstitial syndrome, and pleural effusion.

This prospective observational cohort study is designed to assess the predictive value of perioperative lung ultrasound score in patients undergoing major non-thoracic surgery. A total of 97 patients aged between 18 and 65 years will be included. Lung ultrasound examinations will be performed perioperatively, and LUS scores will be calculated based on standardized protocols.

The primary objective of this study is to evaluate the relationship between perioperative LUS score and early postoperative oxygen requirement. Secondary objectives include assessing the association between LUS score and the incidence of postoperative pulmonary complications, need for intensive care unit admission, and length of hospital stay.

By identifying the predictive role of lung ultrasound scoring, this study aims to contribute to improved perioperative risk stratification and support the use of lung ultrasound as a practical tool in routine anesthetic and surgical care.

02

Conditions studied

  • Postoperative Pulmonary Complications (PPCs)
  • Hypoxemia

Keywords

  • lung ultrasound
  • Lus Score
  • Perioperative Ultrasound
  • Postoperative Complications
  • Oxygen Requirement
  • Non-Thoracic Surgery
  • Anesthesia
03

In context

Hypoxia

1,076 studies on the registry are indexed under Hypoxia; 213 are open to participants now.

This study's planned enrollment of 97 is above the median of 79 across 277 observational studies indexed under Hypoxia.

Browse Hypoxia studies →

Lead sponsor

Dicle University is the lead sponsor of 28 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients aged 18 to 65 years undergoing elective major non-thoracic surgery under general anesthesia with an expected surgical duration of 3 hours or longer at Dicle University Faculty of Medicine Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 to 65 years
  • Scheduled for elective major non-thoracic surgery
  • Undergoing surgery under general anesthesia
  • Expected surgical duration of 3 hours or longer
  • I-III
  • Willing to participate in the study
  • Provides written

Exclusion criteria

Exclusion Criteria:

  • Patients undergoing thoracic or cardiac surgery
  • Advanced chronic lung disease (e.g., severe or pulmonary fibrosis)
  • History of previous lung resection
  • Preoperative pneumonia or active pulmonary infection
  • greater than or equal to 40 kg/m2
  • Pregnancy
  • Emergency surgery
  • Planned postoperative mechanical ventilation or intensive care unit admission
  • Refusal to participate in the study
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
97 participants (estimated)
Patient registry
No

Groups and cohorts

  • atients Undergoing Major Non-Thoracic Surgery

    Patients aged 18 to 65 years undergoing major non-thoracic surgery who will be evaluated using perioperative lung ultrasound score to assess its association with early postoperative oxygen requirement and pulmonary complications.

06

What researchers measure

Primary outcomes

  1. Early Postoperative Oxygen Requirement

    Assessment of the need for supplemental oxygen in the first 24 hours postoperatively and its association with perioperative lung ultrasound score.

    Time frame: Within the first 24 hours after surgery

Secondary outcomes

  1. Postoperative Pulmonary Complications

    Incidence of postoperative pulmonary complications including atelectasis, pneumonia, pleural effusion, respiratory failure, pneumothorax, acute respiratory distress syndrome (ARDS), pulmonary edema, and need for reintubation.

    Time frame: Within 7 days after surgery

  2. Correlation Between LUS Score and Hypoxemia

    Evaluation of the relationship between perioperative lung ultrasound score and postoperative hypoxemia.

    Time frame: Within 24 hours after surgery

  3. Number of participants requiring ICU admission

    Requirement for postoperative intensive care unit admission.

    Time frame: Within 7 days after surgery

  4. Length of Hospital Stay

    Total duration of hospitalization measured in days.

    Time frame: From surgery until hospital discharge (up to 30 days)

  5. Duration of Postoperative Oxygen Therapy

    Total duration of supplemental oxygen therapy required during the first 24 hours postoperatively.

    Time frame: Within the first 24 hours after surgery

  6. Number of participants requiring high-flow nasal oxygen or noninvasive ventilation

    Requirement for advanced respiratory support including high-flow nasal oxygen or noninvasive ventilation in the postoperative period.

    Time frame: Within 7 days after surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to institutional policies and ethical considerations regarding patient confidentiality.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07515001
Lead sponsor
Dicle University
Responsible party
Huseyi̇n Ceti̇k (Resident Physician, Dicle University) — Principal investigator
First posted
Apr 7, 2026
Start date
Apr 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Jan 2027 (estimated)
Last update
Apr 7, 2026

Study contacts

Huseyin Cetik, MD
Contact
huseyincetik@gmail.com
+90 538 970 0171
Zeynep Baysal Yildirim, MD,Professor
principal investigator · Dicle University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion